La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

BICO Group Gestion

Gestion contrôle des critères 2/4

Le PDG BICO Group's est Maria Forss, nommé en Nov2023, a un mandat de moins d'un an. La rémunération annuelle totale est SEK 7.43M, composée du salaire de 6.5% et des bonus 93.5%, y compris les actions et options de la société. détient directement 0.057% des actions de la société, d'une valeur de $ 168.19K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.5 ans et 3.9 ans.

Informations clés

Maria Forss

Directeur général

SEK 7.4m

Rémunération totale

Pourcentage du salaire du PDG	6.5%
Durée du mandat du directeur général	less than a year
Propriété du PDG	0.06%
Durée moyenne d'occupation des postes de direction	1.6yrs
Durée moyenne du mandat des membres du conseil d'administration	4yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Maria Forss a-t-elle évolué par rapport aux bénéfices de BICO Group?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	-SEK 1b
Mar 31 2024	n/a	n/a	-SEK 2b
Dec 31 2023	SEK 7m	SEK 484k	-SEK 2b

Rémunération vs marché: La rémunération totale de Maria ($USD 719.82K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 1.54M ).

Rémunération et revenus: Données insuffisantes pour comparer la rémunération de Maria avec les performances de l'entreprise.

PDG

Maria Forss (52 yo)

less than a year

Titularisation

SEK 7,425,520

Compensation

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Maria Forss	President & CEO	less than a year	SEK 7.43m	0.057% SEK 170.1k
Jacob Thordenberg	Group Chief Financial Officer	1.7yrs	pas de données	0.026% SEK 78.2k
Marius Balger	Chief Operating Officer	1.5yrs	pas de données	pas de données
Asa Hillsten	Senior VP & Head of Investor Relations	no data	pas de données	pas de données
Lotta Bus	SVP, General Counsel	4.7yrs	pas de données	0.0099% SEK 29.7k
Artur Aira	Head of Corporate Development and M&A	1.5yrs	SEK 150.00k	pas de données
Catharina Nordlund	Global Head of Human Resources	less than a year	pas de données	pas de données
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	pas de données	pas de données
Niclas Emanuelsson	Head of Global Operations	4.7yrs	pas de données	pas de données
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.7yrs	pas de données	pas de données
Erica Bell	Senior VP & Chief People Officer	no data	pas de données	pas de données
Nicolas Gabriel-Robez	Chief Security Officer	no data	pas de données	pas de données

1.6yrs

Durée moyenne de l'emploi

52yo

Âge moyen

Gestion expérimentée: L'équipe de direction de CLLK.F n'est pas considérée comme expérimentée (ancienneté moyenne 1.5 ans), ce qui suggère une nouvelle équipe.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Rolf Classon	Independent Chairman of the Board	2.4yrs	SEK 650.00k	0.044% SEK 131.7k
Christian Wildmoser	Independent Director	4.8yrs	SEK 285.00k	0.45% SEK 1.4m
Robert Langer	Member of Scientific Advisory Board	3.8yrs	pas de données	pas de données
Helena Skantorp	Independent Director	4.8yrs	SEK 350.00k	0.0057% SEK 17.0k
Ulrika Dellby	Independent Deputy Chairwoman	2.4yrs	SEK 510.00k	0.027% SEK 80.7k
Bengt Sjoholm	Independent Director	8.7yrs	SEK 285.00k	0.49% SEK 1.5m
Susan Tousi	Independent Director	2.8yrs	SEK 250.00k	pas de données
Ali Khademhosseini	Member of Scientific Advisory Board	7.5yrs	pas de données	pas de données
Ido Amit	Member of Scientific Advisory Board	4.1yrs	pas de données	pas de données
Alexandra Gatzemeyer	Director	less than a year	pas de données	pas de données

4.0yrs

Durée moyenne de l'emploi

66.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de CLLK.F sont considérés comme expérimentés (ancienneté moyenne 3.9 ans).

BICO Group Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

BICO Group AB Announces Management Changes

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) Announces Chief Executive Officer Changes

Recent updates

BICO Group AB Announces Management Changes

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

BICO Group AB (Publ) Announces Board Appointments

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community

CELLINK to Help Develop 3D Bioprinted Personalised Scaffolds for Tissue Regeneration of Ankle Joint S as Part of the Triankle Project

Cellink AB (publ) to Report Second Half, 2020 Results on Oct 22, 2020

Cellink AB (Publ) Announces Leaving Board of Directors for an Operational Role as Business Area Manager for the Bioprinting Business Unit

Cellink AB (publ) (OM:CLNK B) completed the acquisition of SCIENION AG from NRW.Bank Venture Fonds, L.P., managed by NRW.Bank, Investment Arm and other shareholders.

Cellink AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 945.99632 million.

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Âge moyen

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen